Clinical Trial Update: MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLC [Phase 3]

View source ↗

Summary

Phase 3 trial comparing MYL-1402O with Avastin in stage IV non-small cell lung cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• MYL-1402O (Mylotarg? (Note: placeholder))

Snippet

Sponsor: Mylan Pharmaceuticals Inc | Conditions: NSCLC Stage IV | Phase 3 | Status: COMPLETED | Results posted: 2021-02-01